Los Altos, CA, United States of America

De-Mei Leung

This inventor holds 2 USPTO granted patents. Top assignee: Syntex (u.s.a.) Inc.. Active years: 1996.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 1996

Loading Chart...
2 patents (USPTO):Explore Patents

Title: De-Mei Leung: Innovator in Pharmaceutical Compositions

Introduction

De-Mei Leung is a prominent inventor based in Los Altos, CA (US). She has made significant contributions to the field of pharmaceutical compositions, holding a total of 2 patents. Her work focuses on innovative methods for preparing pharmaceutical formulations that enhance treatment efficacy.

Latest Patents

De-Mei Leung's latest patents include a process for preparing pharmaceutical compositions containing crystalline forms of mycophenolate mofetil. One patent details the crystalline anhydrous salt formed by complexing mycophenolate mofetil with anions such as chloride, sulfate, phosphate, and acetate, particularly the hydrochloride salt. This patent also covers pharmaceutical compositions, intravenous formulations, and associated methods of treatment. Another patent focuses on crystalline anhydrous mycophenolate mofetil and its intravenous formulation, emphasizing the same complexing process and its therapeutic applications.

Career Highlights

De-Mei Leung has established herself as a key figure in her field through her innovative research and development efforts. She works at Syntex (U.S.A.) Inc., where she continues to advance pharmaceutical technologies. Her contributions have been instrumental in improving drug formulations and treatment methodologies.

Collaborations

Throughout her career, De-Mei has collaborated with notable colleagues, including Roger C. Fu and Jeffrey S. Fleitman. These partnerships have fostered a collaborative environment that enhances the development of new pharmaceutical solutions.

Conclusion

De-Mei Leung's work in pharmaceutical compositions exemplifies her commitment to innovation in the healthcare sector. Her patents reflect her expertise and dedication to improving patient outcomes through advanced drug formulations.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…